EGF receptor tyrosine kinase inhibition attenuates the development of PKD in Han:SPRD rats (Q44609775)

4 December 2017

title

EGF receptor tyrosine kinase inhibition attenuates the development of PKD in Han:SPRD rats (English)

1 reference

4 December 2017

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00256.X

19 March 2024

1

Vicente E. Torres

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:14531789

19 March 2024

author name string

Xiaofang Wang

3

1 reference

4 December 2017

Qi Qian

4

1 reference

4 December 2017

Philip Frost

6

1 reference

4 December 2017

William E. Sweeney

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:14531789

19 March 2024

Peter C. Harris

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:14531789

19 March 2024

Ellis D. Avner

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:14531789

19 March 2024

language of work or name

English

0 references

publication date

1 November 2003

1 reference

full work available at URL

4 December 2017

http://www.kidney-international.org/article/S0085253815495079/pdf

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:14531789

https://api.elsevier.com/content/article/PII:S0085253815495079?httpAccept=text/xml

19 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00256.X

https://api.elsevier.com/content/article/PII:S0085253815495079?httpAccept=text/plain

19 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00256.X

19 March 2024

1 reference

4 December 2017

volume

64

1 reference

4 December 2017

issue

5

1 reference

4 December 2017

page(s)

1573-1579

1 reference

Can progression of autosomal dominant or autosomal recessive polycystic kidney disease be prevented?

4 December 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00256.X

Defective epidermal growth factor gene expression in mice with polycystic kidney disease

19 March 2024

3

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00256.X

Epidermal growth factor (EGF) expression in the congenital polycystic mouse kidney.

19 March 2024

4

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00256.X

Epidermal growth factor and endothelin in cyst fluid from autosomal dominant polycystic kidney disease cases: possible evidence of heterogeneity in cystogenesis

19 March 2024

7

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00256.X

Hereditary error in epidermal growth factor prohormone metabolism in a rat model of autosomal dominant polycystic kidney disease

19 March 2024

9

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00256.X

Expression of differentiation antigens and growth-related genes in normal kidney, autosomal dominant polycystic kidney disease, and renal cell carcinoma

19 March 2024

10

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00256.X

Expression of transforming growth factor alpha and epidermal growth factor receptor in adult polycystic kidney disease

19 March 2024

11

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00256.X

In vitro formation and expansion of cysts derived from human renal cortex epithelial cells

19 March 2024

12

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00256.X

Tyrosine kinase activity of the EGF receptor in murine metanephric organ culture

19 March 2024

13

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00256.X

In vitro modulation of cyst formation by a novel tyrosine kinase inhibitor.

19 March 2024

14

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00256.X

An activated allele of the c-erbB-2 oncogene impairs kidney and lung function and causes early death of transgenic mice

19 March 2024

16

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00256.X

Targeting of the rasT24 oncogene to the proximal convoluted tubules in transgenic mice results in hyperplasia and polycystic kidneys

19 March 2024

17

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00256.X

Abnormal polarization of EGF receptors and autocrine stimulation of cyst epithelial growth in human ADPKD

19 March 2024

18

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00256.X

Epidermal growth factor receptor expression is abnormal in murine polycystic kidney

19 March 2024

19

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00256.X

Functional activity of epidermal growth factor receptors in autosomal recessive polycystic kidney disease

19 March 2024

20

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00256.X

Epidermal growth factor receptor activity mediates renal cyst formation in polycystic kidney disease

19 March 2024

22

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00256.X

Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitor

19 March 2024

23

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00256.X

Hereditary polycystic kidney disease associated with osteorenal syndrome in rats

19 March 2024

24

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00256.X

Autosomal-dominant polycystic kidney disease in the rat

19 March 2024

25

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00256.X

Irreversible inhibition of epidermal growth factor receptor tyrosine kinase with in vivo activity by N-[4-[(3-bromophenyl)amino]-6-quinazolinyl]-2-butynamide (CL-387,785)

19 March 2024

26

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00256.X

Combinatorial chemoprevention of intestinal neoplasia

19 March 2024

27

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00256.X

Targeted expression of a dominant-negative EGF-R in the kidney reduces tubulo-interstitial lesions after renal injury

19 March 2024

28

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00256.X

Epidermal growth factor rapidly activates the hexose monophosphate shunt in kidney cells

19 March 2024

30

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00256.X

Epidermal growth factor binding, stimulation of phosphorylation, and inhibition of gluconeogenesis in rat proximal tubule

19 March 2024

32

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00256.X

Mouse prepro-epidermal growth factor synthesis by the kidney and other tissues

19 March 2024

33

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00256.X

Potential physiologic roles for epidermal growth factor in the kidney

19 March 2024

34

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00256.X

Expression of transforming growth factor-alpha mRNA and peptide in rodent kidneys

19 March 2024

35

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00256.X

Effect of sodium chloride, enalapril, and losartan on the development of polycystic kidney disease in Han:SPRD rats

19 March 2024

36

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00256.X

Cilazapril delays progression of hypertension and uremia in rat polycystic kidney disease

19 March 2024

37

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00256.X

Hypertension and renal injury in experimental polycystic kidney disease

19 March 2024

38

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00256.X

Epidermal growth factor enhances renal tubule cell regeneration and repair and accelerates the recovery of renal function in postischemic acute renal failure

19 March 2024

39

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00256.X

Epidermal growth factor accelerates renal repair in mercuric chloride nephrotoxicity

19 March 2024

40

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00256.X

Increased distal nephron EGF content and altered distribution of peptide in compensatory renal hypertrophy

19 March 2024

41

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00256.X

Early molecular mechanisms in the progression of renal failure: role of growth factors and protooncogenes

19 March 2024

42

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00256.X

Epidermal growth factor receptor and transforming growth factor alpha expression in papillary and nonpapillary renal cell carcinoma: correlation with metastatic behavior and prognosis

19 March 2024

43

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00256.X

The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein

19 March 2024

44

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00256.X

19 March 2024

Identifiers

1 reference

Dimensions Publication ID

4 December 2017

1028421648

0 references

1 reference